Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Lexicon Pharmaceuticals Inc (NASDAQ:LXRX)

18.42
Delayed Data
As of 3:59pm ET
 +0.05 / +0.27%
Today’s Change
7.65
Today|||52-Week Range
19.62
+38.39%
Year-to-Date
3 Biotechs With Potential Big-Time Upside
Sep 26 / MotleyFool.com - Paid Partner Content
Biotech Stock Roundup: Horizon-Raptor Acquisition Deal, Geron Down on Pipeline News
Sep 14 / Zacks.com - Paid Partner Content
This Diabetes Breakthrough Is Great News or Terrible News, Depending on Your Perspect...
Sep 19 / MotleyFool.com - Paid Partner Content
Is This Lexicon Pharmaceuticals' Year?
Sep 13 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close18.37
Today’s open18.37
Day’s range18.14 - 18.68
Volume590,700
Average volume (3 months)868,957
Market cap$1.9B
Dividend yield--
Data as of 3:59pm ET, 09/27/2016

Growth & Valuation

Earnings growth (last year)+96.24%
Earnings growth (this year)-2,859.01%
Earnings growth (next 5 years)+30.87%
Revenue growth (last year)+468.89%
P/E ratioNM
Price/Sales10.61
Price/Book6.66

Competitors

 Today’s
change
Today’s
% change
IPXLImpax Laboratories I...+0.27+1.04%
OPHTOphthotech Corp+0.82+1.42%
ITCIIntra-Cellular Thera...+0.76+1.86%
TBPHTheravance Biopharma...+1.19+3.33%
Data as of 3:59pm ET, 09/27/2016

Financials

Next reporting dateNovember 1, 2016
EPS forecast (this quarter)-$0.47
Annual revenue (last year)$130.0M
Annual profit (last year)-$4.7M
Net profit margin-3.60%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Lonnel Coats
VP-Marketing, Commercial Strategy &
Operations
John Northcott
Corporate headquarters
The Woodlands, Texas

Forecasts

Search for Jobs